Annual EBITDA
-$121.21 M
-$7000.00-0.01%
31 December 2023
Summary:
Century Therapeutics annual earnings before interest, taxes, depreciation & amortization is currently -$121.21 million, with the most recent change of -$7000.00 (-0.01%) on 31 December 2023. During the last 3 years, it has fallen by -$69.32 million (-133.61%). IPSC annual EBITDA is now -133.61% below its all-time high of -$51.88 million, reached on 31 December 2020.IPSC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$27.94 M
-$213.00 K-0.77%
30 September 2024
Summary:
Century Therapeutics quarterly earnings before interest, taxes, depreciation & amortization is currently -$27.94 million, with the most recent change of -$213.00 thousand (-0.77%) on 30 September 2024. Over the past year, it has increased by +$842.00 thousand (+2.93%). IPSC quarterly EBITDA is now -194.90% below its all-time high of -$9.47 million, reached on 31 March 2020.IPSC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$117.21 M
+$842.00 K+0.71%
30 September 2024
Summary:
Century Therapeutics TTM earnings before interest, taxes, depreciation & amortization is currently -$117.21 million, with the most recent change of +$842.00 thousand (+0.71%) on 30 September 2024. Over the past year, it has dropped by -$4.26 million (-3.77%). IPSC TTM EBITDA is now -1137.30% below its all-time high of -$9.47 million, reached on 31 March 2020.IPSC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.0% | +2.9% | -3.8% |
| 3 y3 years | -133.6% | -13.0% | -48.4% |
| 5 y5 years | - | - | - |
IPSC EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -133.6% | at low | -13.0% | +23.9% | -48.4% | +3.3% |
| 5 y | 5 years | -133.6% | +50.4% | -194.9% | +23.9% | -1137.3% | +3.3% |
| alltime | all time | -133.6% | +50.4% | -194.9% | +23.9% | -1137.3% | +3.3% |
Century Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$27.94 M(+0.8%) | -$117.21 M(-0.7%) |
| June 2024 | - | -$27.72 M(+11.6%) | -$118.05 M(-1.0%) |
| Mar 2024 | - | -$24.84 M(-32.4%) | -$119.30 M(-1.6%) |
| Dec 2023 | -$121.21 M(+0.0%) | -$36.72 M(+27.6%) | -$121.26 M(+7.4%) |
| Sept 2023 | - | -$28.78 M(-0.7%) | -$112.95 M(+1.0%) |
| June 2023 | - | -$28.97 M(+8.1%) | -$111.82 M(-0.1%) |
| Mar 2023 | - | -$26.80 M(-5.6%) | -$111.90 M(-7.7%) |
| Dec 2022 | -$121.20 M | -$28.40 M(+2.7%) | -$121.20 M(+1.3%) |
| Sept 2022 | - | -$27.65 M(-4.8%) | -$119.66 M(+2.5%) |
| June 2022 | - | -$29.05 M(-19.5%) | -$116.72 M(+6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$36.10 M(+34.4%) | -$109.77 M(+20.5%) |
| Dec 2021 | -$91.06 M(+75.5%) | -$26.86 M(+8.6%) | -$91.06 M(+15.3%) |
| Sept 2021 | - | -$24.72 M(+11.9%) | -$78.98 M(+18.1%) |
| June 2021 | - | -$22.10 M(+27.1%) | -$66.88 M(+11.8%) |
| Mar 2021 | - | -$17.39 M(+17.7%) | -$59.80 M(+15.3%) |
| Dec 2020 | -$51.88 M(-78.8%) | -$14.78 M(+17.1%) | -$51.88 M(+39.8%) |
| Sept 2020 | - | -$12.62 M(-16.0%) | -$37.11 M(+51.5%) |
| June 2020 | - | -$15.02 M(+58.5%) | -$24.49 M(+158.5%) |
| Mar 2020 | - | -$9.47 M | -$9.47 M |
| Dec 2019 | -$244.52 M | - | - |
FAQ
- What is Century Therapeutics annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Century Therapeutics?
- What is Century Therapeutics annual EBITDA year-on-year change?
- What is Century Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Century Therapeutics?
- What is Century Therapeutics quarterly EBITDA year-on-year change?
- What is Century Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Century Therapeutics?
- What is Century Therapeutics TTM EBITDA year-on-year change?
What is Century Therapeutics annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of IPSC is -$121.21 M
What is the all time high annual EBITDA for Century Therapeutics?
Century Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$51.88 M
What is Century Therapeutics annual EBITDA year-on-year change?
Over the past year, IPSC annual earnings before interest, taxes, depreciation & amortization has changed by -$7000.00 (-0.01%)
What is Century Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of IPSC is -$27.94 M
What is the all time high quarterly EBITDA for Century Therapeutics?
Century Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$9.47 M
What is Century Therapeutics quarterly EBITDA year-on-year change?
Over the past year, IPSC quarterly earnings before interest, taxes, depreciation & amortization has changed by +$842.00 K (+2.93%)
What is Century Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of IPSC is -$117.21 M
What is the all time high TTM EBITDA for Century Therapeutics?
Century Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$9.47 M
What is Century Therapeutics TTM EBITDA year-on-year change?
Over the past year, IPSC TTM earnings before interest, taxes, depreciation & amortization has changed by -$4.26 M (-3.77%)